Nonhematopoietically Derived DNA Is Shorter than Hematopoietically Derived DNA in Plasma: A Transplantation Model
- 1 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 58 (3), 549-558
- https://doi.org/10.1373/clinchem.2011.169318
Abstract
BACKGROUND: Plasma DNA is predominantly hematopoietic in origin. The size difference between maternal- and fetal-derived DNA in maternal plasma prompted us to investigate whether there was any discrepancy in molecular size between hematopoietically and nonhematopoietically derived DNA in plasma. METHODS: Plasma DNA samples from 6 hematopoietic stem cell transplant recipients and 1 liver transplant recipient were analyzed by massively parallel paired-end sequencing. The size of each fragment was deduced from the alignment positions of the paired reads. In sex-mismatched transplant recipients, the reads from chromosome Y were used as markers for the male donor/recipient. For other transplant recipients, the reads of the donor- and recipient-specific alleles were identified from the single-nucleotide polymorphism genotypes. RESULTS: In male patients receiving female hematopoietic stem cells, more chromosome Y–derived DNA molecules (nonhematopoietically derived) were ≤150 bp than the autosome-derived ones (mainly hematopoietically derived) (median difference, 9.9%). In other hematopoietic stem cell transplant recipients, more recipient-specific DNA molecules (nonhematopoietically derived) were ≤150 bp than the donor-specific ones (hematopoietically derived) (median difference, 14.8%). In the liver transplant recipient, more donor-derived DNA molecules (liver derived) were ≤150 bp than the recipient-derived ones (mainly hematopoietically derived) (difference, 13.4%). The nonhematopoietically derived DNA exhibited a reduction in a 166-bp peak compared with the hematopoietically derived DNA. A 10-bp periodicity in size distribution below approximately 143 bp was observed in both DNA populations. CONCLUSIONS: Massively parallel sequencing is a powerful tool for studying posttransplantation chimerism. Plasma DNA molecules exhibit a distinct fragmentation pattern, with the nonhematopoietically derived molecules being shorter than the hematopoietically derived ones.Keywords
Funding Information
- University Grants Committee (AoE/M-04/06)
- Li Ka Shing Foundation
This publication has 29 references indexed in Scilit:
- Universal noninvasive detection of solid organ transplant rejectionProceedings of the National Academy of Sciences, 2011
- Cell-Free DNA as a Noninvasive Acute Rejection Marker in Renal TransplantationClinical Chemistry, 2009
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaProceedings of the National Academy of Sciences of the United States of America, 2008
- Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- Persistent Aberrations in Circulating DNA Integrity after Radiotherapy Are Associated with Poor Prognosis in Nasopharyngeal Carcinoma PatientsClinical Cancer Research, 2008
- The Origin of Circulating Free DNAClinical Chemistry, 2007
- Prenatal diagnosis: progress through plasma nucleic acidsNature Reviews Genetics, 2006
- Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU RepeatsClinical Chemistry, 2006
- Soluble Donor DNA Concentrations in Recipient Serum Correlate with Pancreas-Kidney RejectionClinical Chemistry, 2006
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980